单味药治疗肝纤维化研究进展  

Research Advances of Single Medicine in the Treatment of Hepatic Fibrosis

作　　者：张莎莎[1] 吕文良[1] 张旭[2] 陈兰羽[1] 徐晨光[1] 李娟梅[1] 

机构地区：[1]中国中医科学院广安门医院感染疾病科,北京100053 [2]上海交通大学附属上海市第一人民医院,上海200080

出　　处：《辽宁中医药大学学报》2012年第7期77-79,共3页Journal of Liaoning University of Traditional Chinese Medicine

基　　金：国家传染病重大专项资助项目(2009ZX10005-017);北京市中医药管理局资助项目(SF-2007-Ⅲ-31)

摘　　要：中医药抗肝纤维化日益成为关注的焦点,而现代中医不仅要了解传统中药的功效,还要对单味中药的现代药理研究有更全面的了解,这样对于临床用药辨证治疗会起到极其重要的作用,文章将常用的治疗肝纤维化的中药从现代药理研究的角度作以综述。The treatment with Traditional Chinese Medicine （ TCM ） of hepatic fibrosis is increasingly becoming the focus of attention. Modern TCM is not only to understand the efficacy of traditional Chinese medicine, but also to have a more comprehensive understanding of the modern pharmacological research on Chinese medicine. Therefore, this can play an important part in the dialectical treatment of clinical medicine. This article will use the treatment of hepatic fibrosis in TCM from the perspective of modern pharmacological research, summarizing as follows.

关 键 词：慢性乙肝 单味药治疗 综述 

分 类 号：R575[医药卫生—消化系统]